News

Coming up on November 1 from 8:30 a.m. to 4:30 p.m., we will present our 9th Annual Research Retreat Day!

Hosted by Dr. Myles Wolf, Chair, Dr. John Leonard & Dr. Steven Lipkin: Enjoy an all-day symposium featuring poster sessions and lectures with a keynote address at 3:30 p.m.in Uris titled “Integrated Inpatient and Outpatient Care for Socioeconomically Diverse Medicare Patients at Increased Risk of Hospitalization: Results from two Randomized Trials of the Comprehensive Care...

Researchers from Weill Cornell Medicine, including co-corresponding author Dr. Robert Schwartz, an associate professor of medicine in the division of Gastroenterology & Hepatology, have used a cutting-edge model system to uncover the mechanism by which SARS-CoV-2, the virus that causes COVID-19, induces new cases of diabetes, and worsens complications in people who already have it. The team found that viral exposure activates immune cells that in turn destroy beta (β) cells, the...

Drs. Lishomwa Ndhlovu and Dr. Michael Corley in the Division of Infectious Diseases, along with the epigenetics company TruDiagnostic, have uncovered DNA markers associated with retroelements, remnants of ancient viral genetic material, in our genes that act as highly accurate epigenetic clocks predicting chronological age. The results support the idea that certain retroelements in the human genome may be involved in aging.

Dr. Michael Corley and Dr. Lishomwa...

With new NIH funding, Weill Cornell Medicine investigators will explore how alterations to the packaging of DNA that affect gene expression, known as epigenetic changes, influence the trajectory of diffuse large B-cell lymphomas. Credit: Shutterstock

A new $12.4 million investigator-initiated Program Project grant co-led by Dr. Leandro Cerchietti, the Richard A. Stratton Associate Professor in the Division of Hematology and Medical Oncology, will support a collaborative, multi-...